Rand Paul Files Disclosure 16 Months Late Showing Wife Invested In Remdesivir Maker

A spokeswoman said Kelley Paul lost money on the investment in Gilead Sciences, which makes an antiviral drug used to treat the coronavirus.

Sen. Rand Paul (R-Ky.) reportedly disclosed Wednesday that his wife bought stock in Gilead Sciences, which makes an antiviral drug used to treat the coronavirus, just weeks before the full threat of the COVID-19 pandemic came to public light. According to The Washington Post, Paul filed paperwork to show that his wife, Kelley Paul, invested in Gilead in Feb. 2020. The pharmaceutical company makes remdesivir, an antiviral drug that was given to former President Donald Trump when he tested positive for COVID-19 in October. Paul is a member of the Senate health committee, which began receiving briefings on COVID-19 in Jan. 2020. Paul’s disclosure came 16 months after the deadline mandated by the Stock Act, which requires lawmakers to report such details within 45 days to prevent insider trading.